https://www.selleckchem.com/pr....oducts/2-deoxy-d-glu
ffect PKA activity by lowering cAMP. Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) uses full-length angiotensin converting enzyme 2 (ACE2) as a main receptor to enter target cells. The goal of this study was to demonstrate the preclinical efficacy of a novel soluble ACE2 protein with increased duration of action and binding capacity in a lethal mouse model of COVID-19. A human soluble ACE2 variant fused with an albumin binding domain (ABD) was linked a dimerization motif hinge-like 4-cysteine dodecapeptide
Aimer
Commentaire
Partagez
